Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

British Journal of Pharmacology

Volumn 132, Issue 3, 2001, Pages 631-640

  Ross, Ruth A ^a   Gibson, T Michael ^a   Brockie, Heather C ^a   Leslie, Mark ^a   Pashmi, Ghazaleh ^a   Craib, Susan J ^a   Di Marzo, Vincenzo ^b   Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b CNR   (Italy)

Author keywords

AM404; Anandamide; Arvanil; Cannabinoid; Capsaicin; Mouse vas deferens; RTX; Structure activity; Vanilloid; VR1 transfected cells

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; ARVANIL; CALCIUM ION; CANNABINOID; CAPSAICIN; CAPSAZEPINE; DRUG ANALOG; DRUG METABOLITE; METHANANDAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; RESINIFERATOXIN; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; WIN 5512;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHO CELL; DRUG INHIBITION; GENETIC TRANSFECTION; LIGAND BINDING; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

EID: 0035116496     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703850     Document Type: Article

References (27)

1. Capsazepine - A competitive antagonist of the sensory neuron excitant capsaicin
2. 50) of an enzymatic reaction
3. Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist
4. Direct activation of capsaicin receptors by products of lipoxygenase: Endogenous capsaicin-like substances
5. The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1)
6. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel
7. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
8. A comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat isolated urinary bladder and vas deferens
9. Discovery and characterization of endogenous cannabinoids
10. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): Vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors
11. 2 receptors
12. Pharmacology of cannabinoid receptor ligands
13. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
14. Cannabinoid receptors and pain
15. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations
16. 2) cannabinoid receptors
17. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
18. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
19. Anandamide: An endogenous activator of the vanilloid receptor
20. Effect of the putative vanilloid receptor agonist, anandamide on the baseline tone in the guinea-pig bronchus
21. Vanilloid (capsaicin) receptors and mechanisms
22. Anandamide and the question of its functional role for activation of capsaicin receptors
23. 2 and receptor differentiation: A statistical analysis of competitive antagonism
24. The anandamide transport inhibitor AM404 activates vanilloid receptors
25. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide